2613MO Identifying biomarkers of response to first-line nivolumab plus ipilimumab therapy in patients with metastatic clear cell renal cell carcinoma (mccRCC) enrolled in the COSMIC 313 trial.
Saved in:
| Title: | 2613MO Identifying biomarkers of response to first-line nivolumab plus ipilimumab therapy in patients with metastatic clear cell renal cell carcinoma (mccRCC) enrolled in the COSMIC 313 trial. |
|---|---|
| Authors: | Simsek, B.1 (AUTHOR), Niman, S.M.2 (AUTHOR), El Ahmar, N.1 (AUTHOR), Mohanna, R.A.1 (AUTHOR), Delcea, A.1 (AUTHOR), De Oliveira, G.R.1 (AUTHOR), Laimon, Y.N.1 (AUTHOR), Ascione, L.3 (AUTHOR), Xie, W.4 (AUTHOR), Braun, D.A.5 (AUTHOR), Sun, M.3 (AUTHOR), Saad, E.3 (AUTHOR), El Masri, J.3 (AUTHOR), Freeman, G.J.3 (AUTHOR), Simmons, A.6 (AUTHOR), Aftab, D.7 (AUTHOR), Motzer, R.J.8 (AUTHOR), Atkins, M.B.9 (AUTHOR), Choueiri, T.K.10 (AUTHOR), Signoretti, S.1 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1402-S1403. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189420992 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 2613MO Identifying biomarkers of response to first-line nivolumab plus ipilimumab therapy in patients with metastatic clear cell renal cell carcinoma (mccRCC) enrolled in the COSMIC 313 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Simsek%2C+B%2E%22">Simsek, B.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Niman%2C+S%2EM%2E%22">Niman, S.M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22El+Ahmar%2C+N%2E%22">El Ahmar, N.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mohanna%2C+R%2EA%2E%22">Mohanna, R.A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Delcea%2C+A%2E%22">Delcea, A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22De+Oliveira%2C+G%2ER%2E%22">De Oliveira, G.R.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Laimon%2C+Y%2EN%2E%22">Laimon, Y.N.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ascione%2C+L%2E%22">Ascione, L.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xie%2C+W%2E%22">Xie, W.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Braun%2C+D%2EA%2E%22">Braun, D.A.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+M%2E%22">Sun, M.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saad%2C+E%2E%22">Saad, E.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22El+Masri%2C+J%2E%22">El Masri, J.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Freeman%2C+G%2EJ%2E%22">Freeman, G.J.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Simmons%2C+A%2E%22">Simmons, A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aftab%2C+D%2E%22">Aftab, D.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Motzer%2C+R%2EJ%2E%22">Motzer, R.J.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Atkins%2C+M%2EB%2E%22">Atkins, M.B.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Choueiri%2C+T%2EK%2E%22">Choueiri, T.K.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Signoretti%2C+S%2E%22">Signoretti, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS1402-S1403. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189420992 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.3228 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S1402 Titles: – TitleFull: 2613MO Identifying biomarkers of response to first-line nivolumab plus ipilimumab therapy in patients with metastatic clear cell renal cell carcinoma (mccRCC) enrolled in the COSMIC 313 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Simsek, B. – PersonEntity: Name: NameFull: Niman, S.M. – PersonEntity: Name: NameFull: El Ahmar, N. – PersonEntity: Name: NameFull: Mohanna, R.A. – PersonEntity: Name: NameFull: Delcea, A. – PersonEntity: Name: NameFull: De Oliveira, G.R. – PersonEntity: Name: NameFull: Laimon, Y.N. – PersonEntity: Name: NameFull: Ascione, L. – PersonEntity: Name: NameFull: Xie, W. – PersonEntity: Name: NameFull: Braun, D.A. – PersonEntity: Name: NameFull: Sun, M. – PersonEntity: Name: NameFull: Saad, E. – PersonEntity: Name: NameFull: El Masri, J. – PersonEntity: Name: NameFull: Freeman, G.J. – PersonEntity: Name: NameFull: Simmons, A. – PersonEntity: Name: NameFull: Aftab, D. – PersonEntity: Name: NameFull: Motzer, R.J. – PersonEntity: Name: NameFull: Atkins, M.B. – PersonEntity: Name: NameFull: Choueiri, T.K. – PersonEntity: Name: NameFull: Signoretti, S. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
